Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.
Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function.
Cell. 1989 Jul 14;58(1):205-14. Unique Identifier : AIDSLINE MED/89324054 Malim MH; Bohnlein S; Hauber J; Cullen BR; Howard Hughes Medical Institute, Duke University Medical Center,; Durham, North Carolina 27710.
Abstract:
Human immunodeficiency virus type 1 (HIV-1) encodes a nuclear trans-activator, termed Rev, that is required for the expression of the viral structural proteins and, hence, for viral replication. The Rev protein acts posttranscriptionally to induce the sequence-specific nuclear export of unspliced HIV-1 mRNA species that are otherwise excluded from the cell cytoplasm. We have used site-directed mutagenesis to identify two distinct regions of the HIV-1 Rev protein that are required for in vivo biological activity. The larger and more N-terminal of these two regions includes, but extends beyond, an arginine-rich sequence element required for nuclear localization. Mutation of a second, more C-terminal Rev protein sequence element was found to yield defective Rev proteins that act as trans-dominant inhibitors of Rev function. These Rev mutants are shown to inhibit HIV-1 replication when expressed in transfected cells and may have potential application in the treatment of HIV-1 related disease.
Keywords: Amino Acid Sequence Animal Cells, Cultured Cercopithecus aethiops DNA Mutational Analysis Gene Expression Regulation HIV/*GENETICS Molecular Sequence Data Nuclear Proteins/PHYSIOLOGY Phosphoproteins/PHYSIOLOGY Phosphorylation Precipitin Tests Repressor Proteins/PHYSIOLOGY Retroviridae Proteins/*PHYSIOLOGY Structure-Activity Relationship Transcription Factors/*PHYSIOLOGY Transcription, Genetic JOURNAL ARTICLE
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.